Global trends in resistance studies of gemcitabine and pancreatic cancer: a bibliometric and visual analysis from 2010 to 2024

Global trends in resistance studies of gemcitabine and pancreatic cancer: a bibliometric and visual analysis from 2010 to 2024

IntroductionPancreatic adenocarcinoma (PC) represents a prevalent and highly aggressive malignancy within the digestive system, characterized by an exceedingly poor prognosis and a dismal 5-year survival rate of below 7%. Gemcitabine (GEM) remains the cornerstone chemotherapeutic agent in the manage...

Full description

Saved in:
Bibliographic Details
Main Authors: Dandan Gu, Shaoyang Huang, Kai Zhao, Xiaohong Zhang, Jinjing Zhang, Wei Xiong
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Pharmacology
Subjects:
pancreatic cancer
gemcitabine
drug resistance
citespace
VOSviewer
bibliometric analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1564561/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items